CMS Evidentiary Priorities

CMS evidence review | evidence_type=MEDCAC Meeting | record_type=medcac_meeting | document_id=41 | meeting_date=2007-10-22

On October 22, 2007 CMS will convene a public meeting of the Medicare Evidence Development & Coverage Advisory Committee (MedCAC) entitled Evidentiary Priorities for the Medicare Program. Numerous issues affect the health and healthcare of our Medicare beneficiaries. Certain disease processes account for a large percentage of services provided to our beneficiaries. Specific treatments and healthcare delivery processes have a great impact on beneficiaries’ outcomes. The purpose of this MedCAC is to assist CMS in developing priorities for evidence development for issues of major importance to the Medicare program and the Medicare population. These issues will provide a framework for the scientific community interested in developing evidence that will impact the health of Medicare beneficiaries. We have assembled a MedCAC panel qualified to discuss research priorities with the most potential to the Medicare population. High profile experts from the scientific community will serve on this panel. Experts from the NIH institutes will present the most relevant research topics. The CDC, AHRQ, and Medicare representatives will describe data resources available in their respective agencies. . The end product of the MedCAC is a priority list of research topics with the most potential impact on Medicare and Medicare beneficiaries to contribute to the body of medical evidence specific to the Medicare populations. Presentations and Written Comment: We are soliciting comments from the scientific community on prioritizing these issues for the Medicare population. Presentations and written comments must be received by September 17, 2007 5:00pm, est. Presentations once submitted are final. We recommend presentations to be in Power Point. Please email your presentations to MedCACpresentations@cms.hhs.gov Registration: The Coverage and Analysis Group is coordinating meeting registration. While there is no registration fee, individuals must register to attend. Register by contacting Maria Ellis maria.ellis@cms.hhs.gov by phone or e-mail. Please provide your full name (as it appears on your state issued driver’s license), address, organization, telephone, fax number(s), and e-mail address. You will receive a registration confirmation with instructions for your arrival at the CMS complex. You will be notified if the seating capacity has been reached. This meeting is located on Federal property; therefore, for security reasons, any individuals wishing to attend this meeting must register by close of business on October 15, 2007 . Security: This meeting will be held in a Federal government building; therefore, Federal security measures are applicable. In planning your arrival time, we recommend that you arrive reasonably early to allow additional time to clear security. In order to gain access to the building and grounds, individuals must present government issued photographic identification to the Federal Protective Service or Guard Service personnel before being allowed entrance. Security measures also include a full inspection of vehicles, inside and exterior areas (rear trunk and engine) at the entrance to the grounds. In addition, all individuals entering the building must pass through a metal detector. All items brought to CMS, whether personal or for the purpose of or support of a demonstration, are subject to inspection. We cannot assume responsibility for coordinating the receipt, transfer, transport, storage, set-up, safety, or timely arrival of any personal belongings or items used for demonstration or to support a demonstration. Parking permits and instructions will be issued upon arrival. Note: Individuals who are not registered in advance will not be permitted to enter the building and will be unable to attend the meeting. The public may not enter the building earlier than 30 to 45 minutes prior to the convening of the meeting. All visitors must be escorted in areas except for the lower and first floor levels in the Central Building.

Actions Taken: September 5, 2007 Announced MedCAC meeting and posted Federal Register notice [PDF, 406KB]. September 7, 2007 Posted questions to panel. October 18, 2007 Posted agenda , invited presenters list , roster and speakers list . October 24, 2007 Posted presentations [PDF, 955KB] from meeting. October 30, 2007 Posted MedCAC Recommended Top 100 Medicare Research Priorities [PDF, 59KB]. Agenda: Federal Register Notice Agenda Medicare Coverage Advisory Committee October 22, 2007 8:00 AM - 4:30 PM CMS Auditorium Barbara McNeil, MD, PhD , Chair Barry M. Straube, MD CMS Chief Medical Officer Director, Office of Clinical Standards and Quality Michelle Atkinson , Executive Secretary 7:30 - 8:00 AM Registration 8:00 - 8:15AM Opening Remarks— M. Atkinson / B. Straube, MD, MPA/ Barbara McNeil, MD, PhD 8:15- 8:25 AM CMS Welcome Presentation - Herb B. Kuhn 8:25 - 8:40AM CMS Presentation - Rosemarie Hakim, MS, PhD 8:40- 8:55AM Peter Savage, FAHA , Special Advisor for Clinical Research, Office of the Director, NHLBI 8:55 - 9:10 AM Martin L. Brown, Ph.D ., Chief, Health Services and Economics Branch, Applied Research Program Division of Cancer Control and Population Sciences National Cancer Institute 9:10 - 9:20AM Susan Nayfield, MD , Chief of the Geriatrics Branch, National Institute on Aging 9:20 -9:35 AM Michael Schoenbaum, PhD , Senior for Mental Health Services, Epidemiology, and Economics Advisor, Division of Services and Intervention Research, National Institute of Mental Health 9:35- 9:50AM Judith Fradkin, M.D . Director, Division of Diabetes, Endocrinology and Metabolic Diseases NIDDK, NIH 9:50 - 10:05AM Walter Koroshetz, MD , National Institute of Neurological Disorders and Stroke 10:05 - 10:20AM Madeline K. Turkeltaub , CRNP, PhD, FAAN, Deputy Director, Extramural Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases 10:20 - 10:35AM Rick Ferris, MD , National Eye Institute 10:35 - 11:15AM Scheduled Public Comment (Refer to the Speakers List) 11:15 - 11:35PM Open Public Comments 11:35 - 12:00PM Questions to Presenters Public Attendees who wish to address the panel will be given that opportunity ****************************************************************************** Public attendees, who have contacted the executive secretary prior to the meeting, will address the panel and present information relevant to the agenda. Speakers are asked to state whether or not they have any financial involvement with manufacturers of any products being discussed or with their competitors and who funded their travel to this meeting. ****************************************************************************** 12:00- 1:00PM LUNCH (On your own) 1:00- 4:00PM Initial Open Panel Discussion: Dr. McNeil 4:00 - 4:25 PM Final Open Panel Discussion: Dr. McNeil 4:25 - 4:30 PM Closing Remarks / Adjournment: Dr. Straube, Dr. McNeil 4:30 PM ADJOURN Invited Presenters List: October 22, 2007 MedCAC Invited Presenters List Peter Savage, FAHA Special Advisor for Clinical Research, Office of the Director, NHLBI Bethesda, Maryland Martin Brown, PhD Chief Health Services and economics Branch Applied Research Program Division of Cancer Control and Population Sciences National Cancer Institute Bethesda, Maryland Susan Nayfield, MD Chief of the Geriatrics Branch, National Institute on Aging Bethesda, Maryland Michael Schoenbaum, PhD Senior for Mental Health Services Epidemiology, and Economics Advisor Division of Services and Intervention Research National Institute of Mental Health Bethesda, Maryland Judith Fradkin, MD Director, Division of Diabetes, Endocrinology and Metabolic Diseases National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland Walter Koroshetz, MD Deputy Director, National Institute of Neurologic Disorders and Stroke National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland Madeline Turkeltaub, CRNP, PhD, FAAN Deputy Director, Extramural Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases Bethesda, Maryland Rick Ferris, MD National Eye Institute Bethesda, Maryland Edward J. Sondik, Ph.D. National Center for Health Statistics Centers for Disease Control and Prevention Hyattsville, MD Issue: On October 22, 2007 CMS will convene a public meeting of the Medicare Evidence Development & Coverage Advisory Committee (MedCAC) entitled Evidentiary Priorities for the Medicare Program. Numerous issues affect the health and healthcare of our Medicare beneficiaries. Certain disease processes account for a large percentage of services provided to our beneficiaries. Specific treatments and healthcare delivery processes have a great impact on beneficiaries’ outcomes. The purpose of this MedCAC is to assist CMS in developing priorities for evidence development for issues of major importance to the Medicare program and the Medicare population. These issues will provide a framework for the scientific community interested in developing evidence that will impact the health of Medicare beneficiaries. We have assembled a MedCAC panel qualified to discuss research priorities with the most potential to the Medicare population. High profile experts from the scientific community will serve on this panel. Experts from the NIH institutes will present the most relevant research topics. The CDC, AHRQ, and Medicare representatives will describe data resources available in their respective agencies. . The end product of the MedCAC is a priority list of research topics with the most potential impact on Medicare and Medicare beneficiaries to contribute to the body of medical evidence specific to the Medicare populations. Presentations and Written Comment: We are soliciting comments from the scientific community on prioritizing these issues for the Medicare population. Presentations and written comments must be received by September 17, 2007 5:00pm, est. Presentations once submitted are final. We recommend presentations to be in Power Point. Please email your presentations to MedCACpresentations@cms.hhs.gov Registration: The Coverage and Analysis Group is coordinating meeting registration. While there is no registration fee, individuals must register to attend. Register by contacting Maria Ellis maria.ellis@cms.hhs.gov by phone or e-mail. Please provide your full name (as it appears on your state issued driver’s license), address, organization, telephone, fax number(s), and e-mail address. You will receive a registration confirmation with instructions for your arrival at the CMS complex. You will be notified if the seating capacity has been reached. This meeting is located on Federal property; therefore, for security reasons, any individuals wishing to attend this meeting must register by close of business on October 15, 2007 . Security: This meeting will be held in a Federal government building; therefore, Federal security measures are applicable. In planning your arrival time, we recommend that you arrive reasonably early to allow additional time to clear security. In order to gain access to the building and grounds, individuals must present government issued photographic identification to the Federal Protective Service or Guard Service personnel before being allowed entrance. Security measures also include a full inspection of vehicles, inside and exterior areas (rear trunk and engine) at the entrance to the grounds. In addition, all individuals entering the building must pass through a metal detector. All items brought to CMS, whether personal or for the purpose of or support of a demonstration, are subject to inspection. We cannot assume responsibility for coordinating the receipt, transfer, transport, storage, set-up, safety, or timely arrival of any personal belongings or items used for demonstration or to support a demonstration. Parking permits and instructions will be issued upon arrival. Note: Individuals who are not registered in advance will not be permitted to enter the building and will be unable to attend the meeting. The public may not enter the building earlier than 30 to 45 minutes prior to the convening of the meeting. All visitors must be escorted in areas except for the lower and first floor levels in the Central Building. Other Material: Transcript 1 Presentations Panel Voting Questions: CMS Evidentiary Priorities in Medicare Questions Which diseases represent the greatest burden to Medicare beneficiaries? Which diseases and their treatments are the costliest to the Medicare Program? Where are our greatest deficits in knowledge about the most important diseases and their treatments in the Medicare population as discussed in Questions 1 and 2? How do we approach the problem of increasing the evidence base for the most important diseases and their treatments in the Medicare population as discussed in Questions 1 and 2? Please provide a priority list of diseases and their treatments that are most critical to increasing the evidence base for making coverage decisions that affect the Medicare population based on your discussions of the above questions. Roster: October 22, 2007 MedCAC Roster Barbara McNeil, MD, PhD CHAIR Acting Dean Harvard Medical School Boston, MA Mark D. Grant, MD, MPH Senior Scientist BlueCross BlueShield Association Chicago, IL Mark A. Hlatky, MD Professor, Health Research and Policy and Cardiovascular Medicine Stanford University School of Medicine Stanford, CA Deborah Schrag MD, MPH Memorial Sloan-Kettering Cancer Center New York, NY Ruth Bush, MD, MPH Associate Professor Division of Vascular Surgery Houston, TX Karl Matuszewski, MS, PharmD University Healthsystem Consortium (UHC) Clinical Practice Advancement Center Oak Brook, IL Nancy Davenport-Ennis, BA CEO Patient Advocate Foundation Newport News, VA Leslie B. Fried, JD American Bar Association Commission on Law & Aging Washington, DC Industry Representative Peter Juhn, MD, MPH Vice President, Evidence & Regulatory Policy Johnson & Johnson, Inc. New Brunswick, NJ Consumer Representative Linda A. Bergthold, PhD Santa Cruz, CA Past Administrator Thomas A. Scully, J.D. Welsh, Carson, Anderson & Stowe New York, NY Guest Panel members Jean Slutsky, PA, MSPH Director, Center for Outcomes and Evidence Agency for Healthcare Research and Quality Rockville, MD Michael A. Jacobs, MD Chief of Orthopedic Surgery Good Samaritan Hospital Baltimore, MD Sean Tunis, MD, MSc Director, Center for Medical Technology Policy Baltimore MD CMS Liaison Barry M. Straube, MD CMS Chief Medical Officer Director, Office of Clinical Standards and Quality Executive Secretary Michelle Atkinson Speaker List: Medicare Coverage Advisory Committee October 22, 2007 SPEAKER LIST * 9 MINUTES PER SPEAKER* Steven Glassman, MD , Orthopedic Surgeon, Spine Institute, Professional Society Coalition Task Force on Lumbar Spine Fusion, and Daniel K. Resnick , MD , University of Wisconsin Medical School William Weintraub, MD , American Heart Association (AHA) Randy Burkholder , Associate Vice President, Policy, PhRMA Ann-Marie Lynch , AdvaMed